Prodia the CRO

Home    Contact Us     News     Events     Download     Career     Login

News

Prodia the CRO, 2015 Frost & Sullivan Indonesia Contract Research Organization

Frost_and_Sullivan_2015PT. Prodia DiaCRO Laboratories (Prodia the CRO) has won the “Contract Research Organization of The Year” for the second consecutive time at the 2015 Frost and Sullivan Indonesia Excellence Award. This event was organized by Frost and Sullivan on Thursday, October 1st, 2015 at the Sangri-la Hotel in Jakarta. The award was representatively given to Erizal Sugiono, Ph.D (General Manager of Prodia the CRO).

PT. Prodia DiaCRO Laboratories is the first local contract research organization (CRO) that established for almost 8 years in Indonesia. Currently this company has been operating not only as a CRO, but also as a newly established site management organization (SMO). As a CRO, Prodia the CRO has been working with 475 investigators and 146 sites across Indonesia. As an SMO, Prodia the CRO work to intensify Indonesian site capacity in order to develop “World Class Trial Site”. To establish this, Prodia the CRO in collaboration with 6 public hospitals such as Prof. Dr. Margono Soekarjo Hospital (Purwokerto), Hasanuddin University Hospital (Makassar), Dr. M. Djamil Hospital (Padang), Dr. Hasan Sadikin Hospital (Bandung), Sanglah Hospital (Denpasar) and Dr. Sardjito Hospital (Yogyakarta) are on progress in establishing Clinical Research Unit (CRU) and improving site management by providing high quality study coordinators.

This is the 8th year of Frost & Sullivan to identify various outstanding companies across Indonesia. A total of 52 awards were given to selected companies based in Indonesia. The awards are presented in the following sectors such as healthcare, food, building and environment, power, logistic and ICT. Its intention is to help drive innovation, excellence and a positive change in global economy by recognizing best-in-class products, companies and individual.

Spike Choo, Country Director, Frost & Sullivan Indonesia said, “We have seen some outstanding performance by Indonesian firms in driving growth locally and regionally. We are delighted to be able to share and showcase Indonesia's best companies in their respective fields at the awards ceremony tonight," he added.

The awarded companies were evaluated on actual market performance indicators which include : revenue growth, market share in specific category and growth in market share, demonstrated leadership in new product introduction and innovation, breadth of products and solutions, major customer acquisitions, subscribers and growth in subscriber base and business/market strategy.

For more details on the 2015 Frost & Sullivan Indonesia Excellence Awards, please click  :http://www.frost-apac.com/indonesiaawards/

Bravo, Prodia the CRO!

Last Updated on Wednesday, 07 October 2015 01:59

PT. Prodia the CRO participated in FKUI Enlightenment Exhibition

prodia_-_fkuiFKUI enlightenment exhibition, themed “Creating the Future from the Future in Medical Research”, was held in Faculty of Medicine University of Indonesia, Salemba - Jakarta, on December 4-5, 2014.

During the event, there were medical research cluster exhibition, mini symposia and the official launch of the Medical Education and Research Center (MERC-UI).

It is planned that the research center will occupy the expected Twin Tower which will be completed in December 2015. This research center will have 11 clusters on research, 2 clusters on supporting research and cluster on medical education. The translational research is one of the form of the research that being the primary agenda of FKUI-RSCM.

The event was attended by about 300 participants, from the university, government and industry. Ms. Endang Hoyaranda, the President Director of Prodia Group, participated as speaker in a panel session with the topic “How to establish public-private-partnership in medical research”. Her concern was the quality of the clinical study site and how it would meet the international standard of a world- class clinical trial site. During the event, Prodia also had an exhibition booth, which was visited by many  visitors, mostly researchers from University of Indonesia. FKUI puts a high concern in developing educational and medicine research in Indonesia. Our hope is that this program would give beneficial effect on the governance of global and national health problem. Prodia, which has been acknowledged to have strong commitment in medicine research, will be on the first line to support the idea.

Last Updated on Wednesday, 28 January 2015 10:50

Prodia The CRO, 2014 Frost And Sullivan Indonesia Contract Research Organization of The Year

prodia_receive_award_frostsullivanThe Frost and Sullivan Indonesia CRO of the Year award is presented to the leading company that has shown exemplary performance in terms of top line revenue, use of technology, partnerships, investment trend and growth potential. Prodia the CRO has proven its dominance in the Indonesian market by showing outstanding growth and financial performance. It is the first full service CRO and one of the most experienced and technologically advanced players in the country.

The company has a strong nationwide network, supported by Prodia Laboratory which has over 250 outlets, over 475 investigators from various expertise, and customers that span from local and international companies, CROs and clinical research centres, to local hospitals and universities.

Besides collaborating with global CROs, the company has also forged ties and partnership with global central lab such as Quintiles Lab (QLabs). Prodia has also been actively involved in collaborating with local hospitals and universities to increase their infrastructure capabilities of performing clinical trials.

Technology wise, for laboratory activities, the company has invested a lot in employing state of the art methods of testing that delivers rapid turnaround time with high throughput. The company has given a significant focus to timely deliverance of results within 24 hours of the arrival of the specimens to the labs.

Apart from Prodia the CRO, Prostem, the other company in Prodia Group is also making an effort to collaborate with international players for joint research in newfrostNSullivan2014 trend medicines, such as personalized medicine and stem cell research. It has already begun working with Medipost of Korea to use stem cells to create replacement cartilage for knees called Cartistem. Proline, another company in Prodia Group, is also working with a German partner for the technology and planning to start assembly of medical equipment for primary care in Indonesia at their facility in Cikarang.

The company is perceived to exhibit outstanding management and consistent growth. The company must offer good quality products and/or services and have positive social and economic impact on local and national communities. With such a long list of achievement and exiting future plans, there is no doubt that Prodia the CRO is the worthy recipient of this prestigious award.

For more information regarding to the awarding, please click this 


 

Last Updated on Tuesday, 30 September 2014 02:25

SMO - PT. Prodia DiaCRO Laboratories Held GCP Workshop In Collaboration with Quintiles in RSUP Sanglah Denpasar

PT. Prodia DiaCRO Laboratories were supported by Quintiles in conducting GCP workshop in Denpasar during 4th - 5th July 2014. This workshop has brought together in total 47 physicians from Denpasar and Surakarta. There are 4 participants from RSUD Dr. Moewardi Surakarta. All the participants were enjoying the workshop and passed the GCP Workshop, as well.

smo_gcpWorkshop_sanglah
Last Updated on Monday, 08 September 2014 05:23

SMO - PT. Prodia DiaCRO Laboratories Signed The MoU with RSUP Sanglah Denpasar, Indonesia

PT. Prodia DiaCRO Laboratories together with RSUP Sanglah Denpasar has collaborate in establishing trial site capacity building in Denpasar. This partnership established in July 3rd, 2014. The ceremony took place in RSUP Sanglah. With this collaboration, we took one step further to develop Indonesia become one of Clinical Trial potential sites destination in Clinical Trial.

smo_mou_sanglah
Last Updated on Monday, 01 September 2014 01:01

SMO - PT. Prodia DiaCRO Laboratories Held GCP Workshop In Collaboration with Quintiles in RSUP Dr. M. Djamil Padang

PT. Prodia DiaCRO Laboratories in collaboration with Quintiles were conducting GCP workshop in Padang during 9th - 10th July 2014. This workshop has brought together in total 34 senior physicians into the workshop. The GCP Workshop surely will increase the number of physicians that has knowledge and competence to conduct clinical trial in accordance to GCP. Therefore, hopefully this will help Indonesia in producing high quality and reliable Clinical Trial.

smo_gcpWorkshop_jamilPadang
Last Updated on Monday, 25 August 2014 17:57

SMO - PT. Prodia DiaCRO Laboratories Signed The MoU with RSUP Dr. M. Djamil Padang, Indonesia

PT. Prodia DiaCRO Laboratories collaborated with RSUP Dr. M. Djamil Padang to develop the trial site capacity building. This partnership established in April 10th, 2014. The ceremony took place in RSUP Dr. M. Djamil Padang. With this collaboration, we hope that Padang will become one of Clinical Trial potential sites destination in the future.

smo_mou_jamilPadang
Last Updated on Monday, 25 August 2014 17:54

PT. Prodia DiaCRO Laboratories as sponsor and exhibit in 7th BioPharma ASIA Convention 2014 in Singapore

NEO_4387

7th BioPharma ASIA Convention 2014 was held in Suntec Singapore Convention & Exhibition Centre Level 4, halls 403-405 Singapore during 10-13 March 2014. This event is the biggest convention to pharma, biotech and R&D community to exhibit in ASIA.

PT. Prodia DiaCRO Laboratories as silver sponsor of BioPharma ASIA Convention 2014 was opening a booth No. D14. It was the 5th occasion to PT. Prodia DiaCRO Laboratories as the first and the only local CRO in Indonesia to conduct full service Clinical Trial to attend and exhibit a booth in this event.

On Wednesday, 12th March 2014, President Director of Prodia DiaCRO Laboratories, Mrs. Endang Hoyaranda, convey a topic titled “The Role of SMO: Filling The Gaps Towards High Quality Studies.”

Indonesia has such a huge potential as a place to conduct clinical trial. Therefore we welcome worldwide sponsors to be able to bring clinical trial projects to perform in Indonesia.

IMG_1096

Last Updated on Wednesday, 27 August 2014 04:34

SMO - PT. Prodia DiaCRO Laboratories Held GCP Workshop In Collaboration with Quintiles in RS UNHAS and RSUP Wahidin Sudirohusodo

PT. Prodia DiaCRO Laboratories in collaboration with Quintiles was held a GCP workshop in Makassar during 28th February - 1st March 2014. This workshop attended by 41 senior physicians. The Head of Ethic Committee, Prof. Dr. dr. Suryani As’ad, MSc., SpGK, was also participating in this workshop.

IMG_3063

Last Updated on Friday, 25 April 2014 03:39

SMO - PT. Prodia DiaCRO Laboratories Held GCP Workshop In Collaboration with Quintiles in RSUP Dr. Hasan Sadikin Bandung

Continuing our commitment in capacity building MoU with RSUP Dr. Hasan Sadikin Bandung, in 18th-19th February 2014 PT. Prodia DiaCRO Laboratories in collaboration with Quintiles was held GCP workshop in RSUP Dr. Hasan Sadikin Bandung. There are 39 physicians that participated in the workshop. Most of the physicians were very enthusiastic in participating this workshop.

IMG_2814

Last Updated on Friday, 25 April 2014 03:39

Page 1 of 2

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
line-footer
Home | Sitemap | Term of Services

P.T. Prodia DiaCRO Laboratories (Prodia the CRO)
Prodia Tower, 6th floor, Jl. Kramat Raya No. 150 Jakarta Pusat - 10430, Indonesia
Phone : +62 21 314 4182 (hunting)/ +62 21 3190 3065 (direct)
Fax : +62 21 3190 5036
Email : cro@prodia.co.id


Copyright © 2014 ProdiatheCRO